conferences.iaea.org will be undergoing maintenance between 16-18 of December 2019 to use Nucleus credentials. Visit our help pages for information on how to Register and Sign-in using Nucleus.
28 October 2019 to 1 November 2019
Vienna International Centre
Europe/Vienna timezone
Announcement and Call for Papers

Scientific Programme


The symposium programme will consist of an opening session, plenary sessions, technical sessions, poster and interactive content sessions, exhibitions, and a closing session.
The opening session will include welcoming addresses by representatives of the IAEA, cooperating organizations, and other relevant organizations.
The plenary sessions will continue with a combination of invited keynote presentations and submitted papers addressing the main themes and topics of the symposium.
Each technical session will include presentations and/or panel discussions delivered by participants which will have been selected based on the abstracts submitted.
The symposium will also include poster sessions, and sufficient time will be provided for discussion and interaction with colleagues.
The final plenary session on the last day of the symposium will be dedicated to conclusions and recommendations on the way forward.


The scope of the conference covers, but is not limited to, the following topical areas:

  • Production of PET- and SPECT-based diagnostic, therapeutic and theranostic medical radioisotopes-1

    PRI
  • Production of radionuclide generators

    PRG
  • Production of PET- and SPECT-based diagnostic, therapeutic, and theranostic radiopharmaceuticals

    PRP
  • Quality control and quality assurance of medical radioisotopes and radiopharmaceuticals

    QCA
  • Pre-clinical evaluation of radiopharmaceuticals

    PCE
  • Design of industrial, hospital and centralized radiopharmacy facilities

    DRF
  • Health regulatory aspects related to the production of radiopharmaceuticals

    HRA
  • Education, including e-learning, certification and training methodologies for professionals involved in radiopharmacy

    EDU
  • Nanosized radiopharmaceuticals

    Nanosized radiopharmaceuticals
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×